Clincosm LogoSign in Get a demo

paroxysmal nocturnal hemoglobinuria

Showing 1 - 25 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Paroxysmal Nocturnal Hemoglobinuria Trial in China

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
    • Hefei, Anhui, China
    • +23 more
    Nov 23, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial in Bloemfontein, Cape Town, Pretoria (BCX10013)

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • Bloemfontein, South Africa
    • +2 more
    Oct 20, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial in Tianjin (MY008211A tablets)

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • MY008211A tablets
    • Tianjin, Tianjin, China
      Nstitute of Hematology & Blood Disease Hospital, Chinese Academy
    Sep 17, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial (HRS-5965 tablets)

    Not yet recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • HRS-5965 tablets
    • (no location specified)
    Sep 20, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)

    Available
    • Paroxysmal Nocturnal Hemoglobinuria
    • (no location specified)
    Aug 31, 2023

    Paroxysmal Nocturnal Hemoglobinuria, PNH, Extravascular Hemolysis Trial (Danicopan)

    Available
    • Paroxysmal Nocturnal Hemoglobinuria
    • +2 more
    • (no location specified)
    Aug 1, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (OMS906 Study Drug - 3 mg/kg, OMS906 Study Drug - 5 mg/kg, Ravulizumab)

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • OMS906 Study Drug - 3 mg/kg
    • +2 more
    • Aachen, Germany
    • +4 more
    Jul 25, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial in Kyiv (OMS906 study drug)

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • OMS906 study drug
    • Kyiv, Ukraine
      Omeros Investigational Site
    May 25, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial in China (Eculizumab)

    Not yet recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • Beijing, China
    • +6 more
    May 24, 2023

    Paroxysmal Nocturnal Hemoglobinuria Treated With Anti-C5

    Completed
    • Paroxysmal Nocturnal Hemoglobinuria
    • Anti-C5 antibody treatment
    • Paris, France
      AP-HP Hôpital Saint Louis
    Apr 24, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial in Changsha (MY008211A tablets, MY008211A tablets matched )

    Active, not recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • MY008211A tablets
    • MY008211A tablets matched placebo
    • Changsha, Hunan, China
      The Third Hospital of Changsha
    Apr 13, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial in Changsha (MY008211A tablets)

    Completed
    • Paroxysmal Nocturnal Hemoglobinuria
    • MY008211A tablets
    • Changsha, Hunan, China
      The Third Hospital of Changsha
    Apr 13, 2023

    Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Not yet recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • (no location specified)
    Mar 17, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial run by the Aplastic Anemia and MDS International Foundation

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
      • Bethesda, Maryland
        Aplastic Anemia and MDS International Foundation
      Feb 23, 2023

      Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)

      Not yet recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • (no location specified)
      Feb 22, 2023

      Paroxysmal Nocturnal Hemoglobinuria Trial in Budapest, Ampang (BCX9930)

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Budapest, Hungary
      • +1 more
      Feb 14, 2023

      Paroxysmal Nocturnal Hemoglobinuria Trial (Danicopan)

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Baltimore, Maryland
      • +4 more
      Feb 1, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +36 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jan 23, 2023

      Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074, Soliris)

      Not yet recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • (no location specified)
      Jan 17, 2023

      Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074)

      Not yet recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • (no location specified)
      Jan 17, 2023

      Paroxysmal Nocturnal Hemoglobinuria, PNH Trial in Worldwide (Ravulizumab)

      Completed
      Has Results
      • Paroxysmal Nocturnal Hemoglobinuria
      • PNH
      • Ravulizumab
      • Toronto, Ontario, Canada
      • +15 more
      Dec 7, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in Changsha (MY008211A tablets, Placebo)

      Active, not recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • MY008211A tablets
      • Placebo
      • Changsha, Hunan, China
        The Third Hospital of Changsha
      Nov 30, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Ravulizumab, Pozelimab, Cemdisiran)

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Whittier, California
      • +8 more
      Nov 29, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial (Iptacopan)

      Not yet recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • (no location specified)
      Nov 18, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (ABP 959, Eculizumab)

      Completed
      • Paroxysmal Nocturnal Hemoglobinuria
      • Atlanta, Georgia
      • +23 more
      Nov 3, 2022